- Home
- PAR vs IRON Comparison
PAR vs IRON Comparison
Compare PAR & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAR
- IRON
- Stock Information
- Founded
- PAR 1968
- IRON 2017
- Country
- PAR United States
- IRON United States
- Employees
- PAR N/A
- IRON N/A
- Industry
- PAR Office Equipment/Supplies/Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- PAR Miscellaneous
- IRON Health Care
- Exchange
- PAR Nasdaq
- IRON Nasdaq
- Market Cap
- PAR 2.4B
- IRON 2.1B
- IPO Year
- PAR N/A
- IRON N/A
- Fundamental
- Price
- PAR $37.88
- IRON $68.02
- Analyst Decision
- PAR Strong Buy
- IRON Strong Buy
- Analyst Count
- PAR 7
- IRON 10
- Target Price
- PAR $78.43
- IRON $97.80
- AVG Volume (30 Days)
- PAR 961.3K
- IRON 340.9K
- Earning Date
- PAR 11-07-2025
- IRON 11-11-2025
- Dividend Yield
- PAR N/A
- IRON N/A
- EPS Growth
- PAR N/A
- IRON N/A
- EPS
- PAR N/A
- IRON N/A
- Revenue
- PAR $418,022,000.00
- IRON N/A
- Revenue This Year
- PAR $29.03
- IRON N/A
- Revenue Next Year
- PAR $15.00
- IRON N/A
- P/E Ratio
- PAR N/A
- IRON N/A
- Revenue Growth
- PAR 45.74
- IRON N/A
- 52 Week Low
- PAR $37.29
- IRON $30.82
- 52 Week High
- PAR $82.24
- IRON $69.87
- Technical
- Relative Strength Index (RSI)
- PAR 22.74
- IRON 66.16
- Support Level
- PAR $37.42
- IRON $65.26
- Resistance Level
- PAR $39.25
- IRON $69.87
- Average True Range (ATR)
- PAR 1.34
- IRON 2.52
- MACD
- PAR 0.13
- IRON 0.54
- Stochastic Oscillator
- PAR 8.14
- IRON 80.55
About PAR PAR Technology Corporation
PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.